Hélène Vanacker
Impact in
-
- Ovarian cancer diagnosis and treatment
-
- Uterine Myomas and Treatments
- Endometrial and Cervical Cancer Treatments
Papers in ⓘ
-
- Ovarian cancer diagnosis and treatment 6
- Oncology 17
- CAR-T cell therapy research 6
- PARP inhibition in cancer therapy 4
- Co-authors
- Isabelle Ray‐Coquard (8 shared papers)Mehdi Brahmi (18 shared papers)Armelle Dufresne (14 shared papers)Jean‐Yves Blay (13 shared papers)Daniel Pissaloux (8 shared papers)Franck Tirode (10 shared papers)Christophe Caux (1 shared paper)Marie‐Cécile Michallet (1 shared paper)
- Journals
- Current Opinion in Oncology (4 papers)ESMO Open (3 papers)Annals of Oncology (2 papers)Cancers (2 papers)Cancer (1 paper)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Hélène Vanacker
28 papers receiving 224 citations
Peers
Comparison fields: 5 of 51
- Reproductive Medicine 37
- Obstetrics and Gynecology 32
- Oncology 87
- Pulmonary and Respiratory Medicine 99
- Rheumatology 34
Countries citing papers authored by Hélène Vanacker
This map shows the geographic impact of Hélène Vanacker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Vanacker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Vanacker more than expected).
Fields of papers citing papers by Hélène Vanacker
This network shows the impact of papers produced by Hélène Vanacker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Vanacker. The network helps show where Hélène Vanacker may publish in the future.
Co-authors
The 25 scholars most cited alongside Hélène Vanacker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 30 | |
| 2 | 2021 | 30 | |
| 3 | 2020 | 25 | |
| 4 | 2020 | 18 | |
| 5 | 2020 | 15 | |
| 6 | 2023 | 11 | |
| 7 | 2020 | 11 | |
| 8 | 2023 | 10 | |
| 9 | 2022 | 9 | |
| 10 | 2020 | 8 | |
| 11 | 2020 | 6 | |
| 12 | 2024 | 5 | |
| 13 | 2017 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2023 | 4 | |
| 16 | 2021 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2024 | 3 | |
| 19 | 2021 | 3 | |
| 20 | [Advanced luminal breast cancer (hormone receptor-positive, HER2 negative): New therapeutic options in 2015]. | 2015 | 3 |
About Hélène Vanacker
Hélène Vanacker is a scholar working on Reproductive Medicine, Oncology, Pulmonary and Respiratory Medicine, Gastroenterology and Rheumatology, having authored 33 papers that have together received 226 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (15 papers), CAR-T cell therapy research (6 papers), Ovarian cancer diagnosis and treatment (6 papers), PARP inhibition in cancer therapy (4 papers), Cardiac tumors and thrombi (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Advanced Breast Cancer Therapies (3 papers) and Palliative Care and End-of-Life Issues (3 papers). The work is most often cited by research in Reproductive Medicine (37 citations), Obstetrics and Gynecology (32 citations), Oncology (87 citations), Pulmonary and Respiratory Medicine (99 citations) and Rheumatology (34 citations). Hélène Vanacker has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Isabelle Ray‐Coquard, Mehdi Brahmi, Armelle Dufresne, Jean‐Yves Blay, Daniel Pissaloux, Franck Tirode, Christophe Caux, Marie‐Cécile Michallet, Sophie Janssens and Jessica Vetters. Their work appears in journals such as Current Opinion in Oncology, ESMO Open, Annals of Oncology, Cancers and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.